Synthesis of [guanido-13C]-γ-hydroxyarginine

Goo Yoon, Mark Zabriskie, Hoon Cheon Seung

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This report describes an efficient method of synthesizing [guanido- 13C]-γ-hydroxyarginine HCl salt. Iodolactonization of N-Boc-protected allylglycine mainly provided the cis iodo compound 2. This was converted to an amine through azide 4. The amine 5 was reacted with N-Boc-protected [13C]thiourea to afford N-Boc-protected [ 13C]guanidine 6, which underwent base catalyzed ring opening. Removal of the N-Boc group afforded [guanido-13C]-γ-hydroxyarginine HCl salt 7 giving a 30% overall yield of the final product from N-Boc protected allylglycine 1 in five steps.

Original languageEnglish (US)
Pages (from-to)53-55
Number of pages3
JournalJournal of Labelled Compounds and Radiopharmaceuticals
Volume52
Issue number2
DOIs
StatePublished - Feb 2009
Externally publishedYes

Fingerprint

Allylglycine
Amines
Salts
Thiourea
Azides
Guanidine

Keywords

  • [Guanido-C]-γ-hydroxyarginine
  • Carbon-13 synthesis
  • Iodolactonization

ASJC Scopus subject areas

  • Analytical Chemistry
  • Organic Chemistry
  • Spectroscopy
  • Drug Discovery
  • Radiology Nuclear Medicine and imaging
  • Biochemistry

Cite this

Synthesis of [guanido-13C]-γ-hydroxyarginine. / Yoon, Goo; Zabriskie, Mark; Seung, Hoon Cheon.

In: Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 52, No. 2, 02.2009, p. 53-55.

Research output: Contribution to journalArticle

@article{95c5afe286b34f758b05244d280a208e,
title = "Synthesis of [guanido-13C]-γ-hydroxyarginine",
abstract = "This report describes an efficient method of synthesizing [guanido- 13C]-γ-hydroxyarginine HCl salt. Iodolactonization of N-Boc-protected allylglycine mainly provided the cis iodo compound 2. This was converted to an amine through azide 4. The amine 5 was reacted with N-Boc-protected [13C]thiourea to afford N-Boc-protected [ 13C]guanidine 6, which underwent base catalyzed ring opening. Removal of the N-Boc group afforded [guanido-13C]-γ-hydroxyarginine HCl salt 7 giving a 30{\%} overall yield of the final product from N-Boc protected allylglycine 1 in five steps.",
keywords = "[Guanido-C]-γ-hydroxyarginine, Carbon-13 synthesis, Iodolactonization",
author = "Goo Yoon and Mark Zabriskie and Seung, {Hoon Cheon}",
year = "2009",
month = "2",
doi = "10.1002/jlcr.1570",
language = "English (US)",
volume = "52",
pages = "53--55",
journal = "Journal of Labelled Compounds and Radiopharmaceuticals",
issn = "0362-4803",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Synthesis of [guanido-13C]-γ-hydroxyarginine

AU - Yoon, Goo

AU - Zabriskie, Mark

AU - Seung, Hoon Cheon

PY - 2009/2

Y1 - 2009/2

N2 - This report describes an efficient method of synthesizing [guanido- 13C]-γ-hydroxyarginine HCl salt. Iodolactonization of N-Boc-protected allylglycine mainly provided the cis iodo compound 2. This was converted to an amine through azide 4. The amine 5 was reacted with N-Boc-protected [13C]thiourea to afford N-Boc-protected [ 13C]guanidine 6, which underwent base catalyzed ring opening. Removal of the N-Boc group afforded [guanido-13C]-γ-hydroxyarginine HCl salt 7 giving a 30% overall yield of the final product from N-Boc protected allylglycine 1 in five steps.

AB - This report describes an efficient method of synthesizing [guanido- 13C]-γ-hydroxyarginine HCl salt. Iodolactonization of N-Boc-protected allylglycine mainly provided the cis iodo compound 2. This was converted to an amine through azide 4. The amine 5 was reacted with N-Boc-protected [13C]thiourea to afford N-Boc-protected [ 13C]guanidine 6, which underwent base catalyzed ring opening. Removal of the N-Boc group afforded [guanido-13C]-γ-hydroxyarginine HCl salt 7 giving a 30% overall yield of the final product from N-Boc protected allylglycine 1 in five steps.

KW - [Guanido-C]-γ-hydroxyarginine

KW - Carbon-13 synthesis

KW - Iodolactonization

UR - http://www.scopus.com/inward/record.url?scp=62849093371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62849093371&partnerID=8YFLogxK

U2 - 10.1002/jlcr.1570

DO - 10.1002/jlcr.1570

M3 - Article

VL - 52

SP - 53

EP - 55

JO - Journal of Labelled Compounds and Radiopharmaceuticals

JF - Journal of Labelled Compounds and Radiopharmaceuticals

SN - 0362-4803

IS - 2

ER -